文献速递心血管胸部MR

SCAN-MRI:整合心脏MRI的2型糖尿病心血管事件预测模型

SCAN-MRI: Cardiac MRI-integrated Risk Score for Predicting Cardiovascular Events in Type 2 Diabetes Mellitus.
PubMed 文献 · Radiology · 2026-01-01

本研究在1388例2型糖尿病患者中开发并验证基于心脏MRI的风险模型,用于预测心衰住院或心血管死亡。SCAN-MRI模型C指数为0.73,AUC为0.76,优于WATCH-DM(0.66)和TRS-HFDM(0.65)模型。将MRI参数加入现有临床模型后,AUC分别提升至0.74和0.73,外部验证C指数为0.71。

要点

  • 心脏MRI参数可提升糖尿病患者心血管事件风险预测能力
  • SCAN-MRI整合性别、冠心病、年龄、房颤、NT-proBNP及MRI变量
  • 在临床风险评分中加入MRI标志物可显著改善鉴别效能

核心结论

  • 基于心脏MRI的多变量风险模型整合临床因素与MRI参数,预测糖尿病患者不良结局的鉴别能力优于现有临床风险模型。

研究设计与样本

  • 前瞻性和回顾性纳入2016年1月至2023年12月接受心脏MRI检查的糖尿病患者,共1388例,平均年龄57岁±12.3,男性955例。
  • 研究分为训练集、内部测试集和外部测试集,主要结局为心衰住院或心血管死亡,中位随访37.6个月。
  • 训练集810例中145例发生主要结局事件,采用多变量Cox回归分析构建风险模型。

关键影像表现/征象

  • SCAN-MRI风险评分基于八个变量:性别、冠心病、年龄、房颤、NT-proBNP及MRI变量。

诊断标准与关键数值

  • SCAN-MRI模型预测3年结局发生率,C指数为0.73,AUC为0.76。
  • 外部测试集中SCAN-MRI风险模型预测不良结局的C指数为0.71。

临床应用与阅片要点

  • 在日常报告糖尿病患者的MRI结果时,可参考SCAN-MRI评分整合的影像变量辅助心血管风险分层。
  • 模型提示单纯依赖临床因素的评分会低估风险,建议同时关注MRI反映的心脏结构和功能参数。

局限性

  • 开发队列部分采用回顾性数据,可能存在选择偏倚;原文注明补充材料可获取。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Patients with diabetes mellitus (DM) are at increased risk of adverse cardiovascular outcomes. Current risk scores for DM rely solely on clinical risk factors and ignore parameters that directly reflect cardiac structure and function such as imaging biomarkers. Purpose To develop a cardiac MRI-based predictive model for cardiovascular outcomes among participants with type 2 DM and evaluate the model in comparison with established clinical risk models. Materials and Methods This study prospectively and retrospectively enrolled participants with DM who underwent cardiac MRI between January 2016 and December 2023, comprising a training set, internal test set, and external test set, in which the risk model was developed and evaluated. The primary outcome was heart failure hospitalization or cardiovascular death. Multivariable Cox regression analysis was performed to develop the risk model. Results Among 1388 participants with DM (mean age, 57 years ± 12.3 [SD]; 955 men), 145 of 810 participants in the training set experienced the primary outcome during a median follow-up of 37.6 months (IQR, 26.5-58.6 months). The MRI-based risk model demonstrated good discrimination (C index, 0.73) and acceptable calibration. On the basis of eight identified risk predictors, an integer-based SCAN-MRI (sex, coronary artery disease, age, atrial fibrillation, N-terminal pro-B-type natriuretic peptide, and MRI variables) risk score was created to predict 3-year outcome incidence. Compared with established WATCH-DM (weight [body mass index], age, hypertension, creatinine, high-density lipoprotein cholesterol, diabetes control [fasting plasma glucose], electrocardiography QRS duration, myocardial infarction, and coronary artery bypass grafting; area under the receiver operating characteristic curve [AUC], 0.66) and Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes risk models (AUC, 0.65), the SCAN-MRI risk model showed better predictive performance (AUC, 0.76; both P < .001). Adding cardiac MRI markers into these risk models improved the discriminative ability to predict adverse outcomes (AUC, WATCH-DM: 0.66 to 0.74 [P < .001]; Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes: 0.65 to 0.73 [P < .001]). In the external test set, the risk model showed good performance in predicting adverse outcomes (C index, 0.71). Conclusion A cardiac MRI-based multivariable risk model, integrating clinical factors and MRI parameters, demonstrated good discrimination and better performance than current established risk models in predicting adverse outcomes in participants with DM. © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Varga-Szemes and Emrich in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yang, Lian, Teng, et al. SCAN-MRI: Cardiac MRI-integrated Risk Score for Predicting Cardiovascular Events in Type 2 Diabetes Mellitus. Radiology. 2026. PMID: 42517762. doi:10.1148/radiol.252374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。